These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10919609)

  • 21. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells.
    Schoels M; Dengler TJ; Richter R; Meuer SC; Giese T
    Clin Transplant; 2004 Oct; 18(5):513-7. PubMed ID: 15344952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamics during humoral rejection events with total versus standard orthotopic heart transplantation.
    Aleksic I; Freimark D; Blanche C; Czer LS; Trento A
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):285-9. PubMed ID: 15563263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
    Horwitz PA; Tsai EJ; Putt ME; Gilmore JM; Lepore JJ; Parmacek MS; Kao AC; Desai SS; Goldberg LR; Brozena SC; Jessup ML; Epstein JA; Cappola TP
    Circulation; 2004 Dec; 110(25):3815-21. PubMed ID: 15583081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements.
    Wu AH; Johnson ML; Aaronson KD; Gordon D; Dyke DB; Koelling TM
    J Heart Lung Transplant; 2005 Jan; 24(1):52-7. PubMed ID: 15653379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases.
    Cohn WE; Gregoric ID; Radovancevic B; Wolf RK; Frazier OH
    Ann Thorac Surg; 2008 Jan; 85(1):56-8. PubMed ID: 18154778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased myocardial performance index correlates with biopsy-proven rejection in pediatric heart transplant recipients.
    Leonard GT; Fricker FJ; Pruett D; Harker K; Williams B; Schowengerdt KO
    J Heart Lung Transplant; 2006 Jan; 25(1):61-6. PubMed ID: 16399532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial.
    Pham MX; Deng MC; Kfoury AG; Teuteberg JJ; Starling RC; Valantine H
    J Heart Lung Transplant; 2007 Aug; 26(8):808-14. PubMed ID: 17692784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children.
    Wåhlander H; Kjellström C; Holmgren D
    Transplantation; 2002 Oct; 74(8):1130-5. PubMed ID: 12438959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
    Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
    J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.
    Hammerer-Lercher A; Mair J; Antretter H; Ruttmann E; Poelzl G; Laufer G; Puschendorf B; Hangler H
    J Heart Lung Transplant; 2005 Sep; 24(9):1444. PubMed ID: 16143273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course.
    Koch A; Burgschweiger A; Herpel E; Sack FU; Schirmacher P; Szabo GB; Karck M; Schnabel PA
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):639-43. PubMed ID: 17689088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation.
    Dizon JM; Chen K; Bacchetta M; Argenziano M; Mancini D; Biviano A; Sonett J; Garan H
    J Am Coll Cardiol; 2009 Nov; 54(22):2043-8. PubMed ID: 19926011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of brain natriuretic peptide gene expression and secretion in acute cardiac allograft rejection.
    de Bold AJ
    Curr Opin Cardiol; 2007 Mar; 22(2):146-50. PubMed ID: 17284995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.
    Bader FM; Rogers RK; Kfoury AG; Gilbert EM; Horne BD; Stehlik J; Renlund DG
    Congest Heart Fail; 2009; 15(2):63-7. PubMed ID: 19379451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.
    Kfoury AG; Stehlik J; Renlund DG; Snow G; Seaman JT; Gilbert EM; Stringham JS; Long JW; Hammond ME
    J Heart Lung Transplant; 2006 Nov; 25(11):1277-82. PubMed ID: 17097489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricuspid valve regurgitation and endomyocardial biopsy after orthotopic heart transplantation.
    Chen RJ; Wei J; Chang CY; Chuang YC; Lee KC; Sue SH; Chen HL
    Transplant Proc; 2008 Oct; 40(8):2603-6. PubMed ID: 18929813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.